印度三级中心四十年新生儿死亡与疾病趋势:队列研究
该回顾性队列纳入印度新德里一家三级公立医院1983至2023年全部80 208例院内出生新生儿,分析八个4至6年时段的死亡率与主要疾病变化。新生儿死亡率从前三个时段30.7/1000活产降至第三时段18.2/1000活产,第八时段为17.6/1000活产;极低出生体重儿存活率由52%升至79%。
要点
- 新生儿死亡率早期显著下降后趋于停滞,第八时段为17.6/1000活产。
- 极低出生体重儿存活率由52%(102/197)升至79%(503/639)。
- 培养阳性脓毒症发生率最后两个时段降至0.7%,病原谱向革兰阳性菌转变。
核心结论
- 尽管疾病严重程度逐步升高,新生儿存活率仍大幅改善,主要源于极低出生体重儿存活率提高。
- 疾病谱和病原谱随时间发生显著变化,感染控制、产前保健及对小婴儿的强化支持可能促进了这些改善。
研究设计与样本
- 回顾性队列研究,纳入印度新德里一家三级学术公立医院1983至2023年全部院内出生新生儿,共80 208例。
- 按八个4至6年时段分析新生儿死亡率、主要疾病及脓毒症。
主要发现
- 新生儿死亡率在前三个时段由30.7/1000活产降至第三时段18.2/1000活产,此后停滞,第八时段为17.6/1000活产。
- 极低出生体重儿存活率由52%(102/197)升至79%(503/639)。
- 严重围产期窒息发生率由2.4%降至1.3%,严重脑室内出血由4.7%降至1.1%,呼吸窘迫综合征由33.1%降至12.5%。
- 主要畸形发生率由2.1%升至3.1%。
- 培养阳性脓毒症初期维持在约1.3%至2%活产,最后两个时段降至0.7%,病原谱向革兰阳性菌占优势转变。
临床怎么用
- 资源有限的三级新生儿单元中,持续加强感染控制、产前保健及对极低出生体重儿的强化支持可能有助于改善存活。
- 应关注脓毒症病原谱向革兰阳性菌转变的趋势,并据此调整经验性抗感染策略。
局限性
- 为单中心回顾性队列研究,结果外推至其他资源环境需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Long-term, hospital-based data on neonatal outcomes from low- and middle-income countries remain scarce, hindering identification of scalable interventions that improve survival in resource-constrained settings. This study aimed to describe secular trends in neonatal mortality and morbidities over four decades in an Indian neonatal unit. DESIGN: Retrospective cohort study. SETTING: Single tertiary-level academic public hospital (New Delhi, India). PARTICIPANTS: All inborn neonates born between 1983 and 2023 (n=80 208). MAIN OUTCOME MEASURES: Neonatal mortality rates (NMR), significant morbidities and sepsis analysed across eight epochs of 4-6 years each. RESULTS: NMR declined considerably in the first three epochs (30.7 to 18.2 per 1000 live births in epoch III) despite an increase in preterm and multiple births but remained stagnant thereafter (17.6 in epoch 8). The survival of very low birthweight neonates increased from 52% (102/197) to 79% (503/639). The incidence of severe perinatal asphyxia (2.4% to 1.3%), severe intraventricular haemorrhage (4.7% to 1.1%) and respiratory distress syndrome (33.1% to 12.5%) decreased, while that of major malformations (2.1% to 3.1%) increased. The incidence of culture-positive sepsis, initially static at around 1.3-2% of live births, declined in the last two epochs (0.7%), with a shift in pathogen profile towards Gram-positive predominance. CONCLUSION: Neonatal survival improved substantially despite progressively higher sickness levels, stemming largely from the improved survival of very low birthweight neonates. We noted significant temporal changes in the morbidity profile and the pathogen profile. Sustained improvements in infection control, antenatal care and intensive support for smaller neonates appear to have contributed to these gains.
引用
- Prakash S, Saksena M, Sahoo T, et al. Trends in neonatal mortality and morbidity at a tertiary centre over four decades: a cohort study. Arch Dis Child. 2026. PMID: 42595474. doi:10.1136/archdischild-2026-330531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。